Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review
Fatemeh Sodeifian, Zahra Sadat Seyedalhosseini, Naghmeh Kian, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method
Rolf Teschke, Nahúm Méndez‐Sánchez, Axel Eickhoff
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4828-4828
Open Access | Times Cited: 37
Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage
Nikhil Kirtipal, Sanjay Kumar, Sumit Kumar Dubey, et al.
Infection Genetics and Evolution (2022) Vol. 99, pp. 105254-105254
Open Access | Times Cited: 33
Management of hepatitis B virus reactivation due to treatment of COVID-19
Terry Cheuk‐Fung Yip, Madeleine Gill, Grace Lai‐Hung Wong, et al.
Hepatology International (2022) Vol. 16, Iss. 2, pp. 257-268
Open Access | Times Cited: 27
COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations
Romina Roshanshad, Amirhossein Roshanshad, Reza Fereidooni, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 4, pp. 441-459
Open Access | Times Cited: 10
Insight into COVID-19 associated liver injury: Mechanisms, evaluation, and clinical implications
Nosheen Nasir
Hepatology forum/Hepatology forum (Online) (2024), pp. 139-149
Open Access | Times Cited: 3
The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome
Lina Naseralallah, Bodoor Aboujabal, Nejat Mohamed Geryo, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0268705-e0268705
Open Access | Times Cited: 14
The des-Arg9-bradykinin/B1R axis: Hepatic damage in COVID-19
Gabriel Moreira de Mello Mendes, Israel Júnior Borges do Nascimento, Paulo HS. Marazzi-Diniz, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 14
Liver injury in COVID-19: an insight into pathobiology and roles of risk factors
Abbas Tazarghi, Sahar Bazoq, M H Taziki, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Hepatic, Extrahepatic and Extracellular Vesicle Cytochrome P450 2E1 in Alcohol and Acetaminophen-Mediated Adverse Interactions and Potential Treatment Options
Santosh Kumar, Bhupesh Singla, Ajay Kumar Singh, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2620-2620
Open Access | Times Cited: 13
Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients
Muhammad Naeem, Naheed Bano, Saba Manzoor, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 99-99
Open Access | Times Cited: 7
Insight into the liver dysfunction in COVID-19 patients: Molecular mechanisms and possible therapeutic strategies
Naina Khullar, Jasvinder Singh Bhatti, Satwinder Singh, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 14, pp. 2064-2077
Open Access | Times Cited: 5
Gastrointestinal Imaging Findings in the Era of COVID-19: A Pictorial Review
Xanthippi Mavropoulou, Elisavet Psoma, Angeliki Papachristodoulou, et al.
Medicina (2023) Vol. 59, Iss. 7, pp. 1332-1332
Open Access | Times Cited: 5
Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines
Nazanin Aghamohamadi, Faezeh Shahba, Ali Zarezadeh Mehrabadi, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 5
SARS-CoV-2 and chronic hepatitis B: Focusing on the possible consequences of co-infection
Shahrzad Shoraka, Seyed Reza Mohebbi, Seyed Masoud Hosseini, et al.
Journal of Clinical Virology Plus (2023) Vol. 3, Iss. 4, pp. 100167-100167
Open Access | Times Cited: 5
COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?
Agata Michalak, Tomasz Lach, Karolina Szczygieł, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2212-2212
Open Access | Times Cited: 1
An Increase in Aspartate Aminotransferase Can Predict Worsening Disease Severity in Japanese Patients with COVID-19
Kengo Matsumoto, Tsutomu Nishida, Dai Nakamatsu, et al.
Clinics and Practice (2024) Vol. 14, Iss. 4, pp. 1601-1614
Open Access | Times Cited: 1
Adverse events following remdesivir administration in moderately ill COVID-19 patients - A retrospective analysis
Gandham Ravi, Madhavi Eerike, Gerard M. Raj, et al.
Journal of Family Medicine and Primary Care (2022) Vol. 11, Iss. 7, pp. 3693-3698
Open Access | Times Cited: 8
SARS-CoV-2-mediated liver injury: pathophysiology and mechanisms of disease
Ali Choaib, Elio Issa, Francesca El Choueiry, et al.
Inflammation Research (2022) Vol. 72, Iss. 2, pp. 301-312
Open Access | Times Cited: 8
Drug-Induced Liver Injury in Hospitalized Patients during SARS-CoV-2 Infection
Eleni Karlafti, Daniel Paramythiotis, Konstantina Pantazi, et al.
Medicina (2022) Vol. 58, Iss. 12, pp. 1848-1848
Open Access | Times Cited: 8
Redefining Lobe-Wise Ground-Glass Opacity in COVID-19 Through Deep Learning and its Correlation With Biochemical Parameters
Budhadev Baral, Kartik Muduli, Shweta Jakhmola, et al.
IEEE Journal of Biomedical and Health Informatics (2023) Vol. 27, Iss. 6, pp. 2782-2793
Closed Access | Times Cited: 4
Layer-by-layer reinforced-mediated sustained-release nanoantioxidants for long-lasting prevention against drug-induced liver injury
Peng Tang, Huiyin Wu, Meng‐Ru Wang, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 230, pp. 113489-113489
Closed Access | Times Cited: 4
Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics and System Biology Analyses: The Role of Pregnane X Receptor
Jingjing Huang, Zhaokang Zhang, Chenxia Hao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Liver tests abnormalities with licensed antiviral drugs for COVID-19: a narrative review
Giacomo Casalini, Andrea Giacomelli, Spinello Antinori
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 12, pp. 1483-1494
Closed Access | Times Cited: 6
Liver function in transgender persons: Challenges in the COVID-19 era
Charalampos Milionis, Ιoannis Ilias, Eftychia Koukkou
World Journal of Clinical Cases (2023) Vol. 11, Iss. 2, pp. 299-307
Open Access | Times Cited: 3
Risk of acute liver injury following the nirmatrelvir/ritonavir use
Carlos King Ho Wong, Lung‐Yi Mak, Ivan Chi Ho Au, et al.
Liver International (2023) Vol. 43, Iss. 12, pp. 2657-2667
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top